Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapies in rare cancers.
Vivekanandhan S, Bahr D, Kothari A, Ashary MA, Baksh M, Gabriel E. Vivekanandhan S, et al. Among authors: baksh m. Mol Cancer. 2023 Feb 1;22(1):23. doi: 10.1186/s12943-023-01720-2. Mol Cancer. 2023. PMID: 36726126 Free PMC article. Review.
Advanced Tumor Imaging Approaches in Human Tumors.
Nussbaum S, Shoukry M, Ashary MA, Kasbi AA, Baksh M, Gabriel E. Nussbaum S, et al. Among authors: baksh m. Cancers (Basel). 2022 Mar 18;14(6):1549. doi: 10.3390/cancers14061549. Cancers (Basel). 2022. PMID: 35326700 Free PMC article. Review.
Age-related Survival Outcomes for Pancreatic Cancer by Age.
Abbaszadeh Kasbi A, Ashary MA, Baksh M, Nussbaum S, Attwood K, Gabriel E. Abbaszadeh Kasbi A, et al. Among authors: baksh m. Cancer Diagn Progn. 2022 Jan 3;2(1):71-77. doi: 10.21873/cdp.10078. eCollection 2022 Jan-Feb. Cancer Diagn Progn. 2022. PMID: 35400009 Free PMC article.
Circulating tumor DNA for breast cancer: Review of active clinical trials.
Baksh M, Mahajan B, Dufresne MM, Shoukry MM, Nussbaum S, Abbaszadeh-Kasbi A, Ashary M, Vandenberg J, Gabriel EM. Baksh M, et al. Cancer Treat Res Commun. 2022;32:100609. doi: 10.1016/j.ctarc.2022.100609. Epub 2022 Jul 12. Cancer Treat Res Commun. 2022. PMID: 35850075 Free article. Review.
How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer?
Huang K, Dufresne M, Baksh M, Nussbaum S, Abbaszadeh Kasbi A, Mohammed A, Advani P, Morozov A, Bagaria S, McLaughlin S, Gabriel E. Huang K, et al. Among authors: baksh m. Am Surg. 2023 Dec;89(12):5414-5420. doi: 10.1177/00031348231156776. Epub 2023 Feb 14. Am Surg. 2023. PMID: 36788122
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
Bansal R, Baksh M, Larsen JT, Hathcock MA, Dingli D, Stewart AK, Kapoor P, Kourelis T, Hayman SR, Warsame RM, Fonseca R, Bergsagel PL, Ailawadhi S, Kumar SK, Lin Y. Bansal R, et al. Among authors: baksh m. Blood Cancer J. 2023 Apr 5;13(1):47. doi: 10.1038/s41408-023-00820-y. Blood Cancer J. 2023. PMID: 37019896 Free PMC article.
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.
Kumar V, Ailawadhi M, Dutta N, Abdulazeez M, Aggarwal CS, Quintero G, Baksh M, Roy V, Sher T, Alegria V, Paulus A, Chanan-Khan A, Ailawadhi S. Kumar V, et al. Among authors: baksh m. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e449-e455. doi: 10.1016/j.clml.2020.12.023. Epub 2020 Dec 24. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33485835
Myelomatous ascites and pleural effusion in relapsed multiple myeloma.
Baksh M, Li K, Jiang L, Alegria V, Sher T, Roy V, Chanan-Khan A, Ailawadhi S, Parrondo RD, Alhaj Moustafa M. Baksh M, et al. Clin Case Rep. 2022 Feb 2;10(2):e05329. doi: 10.1002/ccr3.5329. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35140947 Free PMC article.
58 results